LabCorp Announces Appointment of Chief Financial Officer Read more about LabCorp Announces Appointment of Chief Financial Officer
LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest Read more about LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest
LabCorp is Scheduled to Present at the Barclays Capital 2014 Global Healthcare Conference Read more about LabCorp is Scheduled to Present at the Barclays Capital 2014 Global Healthcare Conference
LabCorp Announces the Availability of Thermo Scientific ImmunoCAP™ Allergy Testing Products Read more about LabCorp Announces the Availability of Thermo Scientific ImmunoCAP™ Allergy Testing Products
Laboratory Corporation of America® Holdings Announces 2013 Fourth Quarter and Full Year Results and Provides 2014 Guidance Read more about Laboratory Corporation of America® Holdings Announces 2013 Fourth Quarter and Full Year Results and Provides 2014 Guidance
LabCorp to Offer New FDA approved Breast Cancer Prognostic Test Read more about LabCorp to Offer New FDA approved Breast Cancer Prognostic Test
LabCorp is Scheduled to Present at the 32nd Annual J.P. Morgan Healthcare Conference Read more about LabCorp is Scheduled to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp Updates 2013 Guidance and Provides Preliminary 2014 Guidance Read more about LabCorp Updates 2013 Guidance and Provides Preliminary 2014 Guidance
LabCorp to Offer the IntelliGENTM Multi-Gene Oncology Panel on the Next Generation Sequencing Platform Read more about LabCorp to Offer the IntelliGENTM Multi-Gene Oncology Panel on the Next Generation Sequencing Platform
